Danaher Corporation $DHR Shares Purchased by Clean Yield Group

Clean Yield Group increased its stake in shares of Danaher Corporation (NYSE:DHR) by 7.7% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 1,004 shares of the conglomerate’s stock after acquiring an additional 72 shares during the period. Clean Yield Group’s holdings in Danaher were worth $198,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of DHR. Nuveen LLC purchased a new stake in Danaher during the 1st quarter worth approximately $833,941,000. Invesco Ltd. increased its holdings in Danaher by 44.5% during the 1st quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate’s stock worth $965,259,000 after purchasing an additional 1,450,703 shares during the last quarter. Baird Financial Group Inc. increased its holdings in Danaher by 290.6% during the 1st quarter. Baird Financial Group Inc. now owns 1,441,706 shares of the conglomerate’s stock worth $295,550,000 after purchasing an additional 1,072,617 shares during the last quarter. Generation Investment Management LLP increased its holdings in Danaher by 33.2% during the 1st quarter. Generation Investment Management LLP now owns 3,178,124 shares of the conglomerate’s stock worth $651,515,000 after purchasing an additional 791,662 shares during the last quarter. Finally, Parnassus Investments LLC increased its holdings in Danaher by 23.3% during the 1st quarter. Parnassus Investments LLC now owns 3,828,024 shares of the conglomerate’s stock worth $784,745,000 after purchasing an additional 722,636 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Trading Up 1.9%

Shares of DHR stock opened at $184.97 on Monday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.59. The stock has a fifty day moving average of $199.44 and a two-hundred day moving average of $197.48. The firm has a market capitalization of $132.45 billion, a PE ratio of 39.36, a price-to-earnings-growth ratio of 2.63 and a beta of 0.75.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. During the same quarter in the previous year, the firm posted $1.72 EPS. The firm’s quarterly revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.7%. Danaher’s dividend payout ratio is 27.23%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. Barclays reiterated an “overweight” rating and issued a $225.00 price target (up from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Deutsche Bank Aktiengesellschaft lowered their price target on Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Scotiabank upgraded Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price target for the company in a report on Friday, July 11th. Wells Fargo & Company lowered their price target on Danaher from $210.00 to $205.00 and set an “equal weight” rating for the company in a report on Wednesday, July 23rd. Finally, Guggenheim restated a “buy” rating and set a $250.00 price objective on shares of Danaher in a research note on Wednesday, July 23rd. Seventeen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average price target of $245.91.

Insider Buying and Selling at Danaher

In other news, Director Teri List sold 2,778 shares of the company’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 11.20% of the stock is currently owned by company insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.